• Horizon Pharma Inc., of Deerfield, Ill., said its Swiss subsidiary signed an exclusive agreement with Mundipharma International Ltd., of Cambridge, UK, for the commercialization and distribution of Lodotra, a delayed-release formulation of prednisone, in the Middle East and African region.